Corporate DisclosureSQURPHARMA
SQURPHARMA Corporate Disclosure — 12 December 2019
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 12 December 2019. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Continuation news of SQURPHARMA): using the acquisition method when control is transferred to the Company. The consideration transferred in the acquisition is generally measured at fair value, as are the identi?able net assets acquired. As the consideration transferred in the acquisition date is equals to net assets acquired at acquisition date, there is no goodwill or gain on bargain purchase arises as per para-9 of lFRS 3. (end)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b000040057ec5
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.